ONCY Oncolytics Biotech Inc.: ערך חשבונאי למניה

The price action of Oncolytics Biotech Inc. (ONCY) reflects market expectations for a business monetizing the innovative Pelareorep virus for long-term tumor treatment, with the current indicator standing at -0.05. Oncolytics Biotech Inc. (ONCY) is developing viral platforms through strategic alliances with major pharmaceutical behemoths, creating synergy in clinical trials. Experienced management is confidently steering the drugs toward final registration, maintaining a high level of investor confidence.

The development of the oncolytic virus Pelareorep by Oncolytics Biotech Inc. (ONCY) creates a significant base of intangible assets, which directly determines the dynamics of the net book value per share. This indicator is calculated as the ratio of equity to the number of shares, allowing investors to assess the real value of their ownership stake and determine the margin of safety of the market price relative to the liquidation value of the business.